e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score
Martínez-García Miguel Á., de Gracia Javier, Vendrell Relat Monserrat, Girón Rosa-Maria, Máiz Carro Luis, de la Rosa Carrillo David, Olveira Casilda
Source:
Eur Respir J 2014; 43: 1357-1367
Journal Issue:
May
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Martínez-García Miguel Á., de Gracia Javier, Vendrell Relat Monserrat, Girón Rosa-Maria, Máiz Carro Luis, de la Rosa Carrillo David, Olveira Casilda. Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. Eur Respir J 2014; 43: 1357-1367
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Cystic fibrosis and intestinal organoids
Related content which might interest you:
LATE-BREAKING ABSTRACT: Multidimensional approach to non-cystic fibrosis bronchiectasis. The FACED score
Source: Annual Congress 2012 - Hot topics in respiratory infections
Year: 2012
Depression and anxiety in patients with cystic fibrosis and non-cystic fibrosis bronchiectasis
Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research
Year: 2009
Global burden of non-cystic fibrosis bronchiectasis: A simple epidemiological analysis
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012
The bronchiectasis severity index and FACED score for bronchiectasis
Source: Eur Respir J 2016; 47: 382-384
Year: 2016
Physical activity evaluation in non-cystic fibrosis bronchiectasis patients
Source: International Congress 2017 – Assessing pulmonary and extra-pulmonary function in chronic disease
Year: 2017
Exercise capacity is related with FACED score for disease severity in non-cystic fibrosis bronchiectasis
Source: International Congress 2016 – Treatment and assessment of functional outcomes in cardiorespiratory physiotherapy
Year: 2016
International validation of FACED score in 672 patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2016 – Clinical update on bronchiectasis
Year: 2016
Small-airway dysfunction among non-cystic bronchiectasis patients with different Bronchiectasis Severity Index
Source: Virtual Congress 2021 – Bronchiectasis
Year: 2021
Global impact of bronchiectasis and cystic fibrosis
Source: Breathe 2016; 12: 222-235
Year: 2016
Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases
Year: 2018
The COPD Assessment Test in patients with non-cystic fibrosis bronchiectasisundergoing pulmonary rehabilitation
Source: International Congress 2018 – Additional latest insights in pulmonary rehabilitation for chronic lung diseases
Year: 2018
Which score is better in association with exercise capacity and QoL in noncystic fibrosis bronchiectasis patients? FACED or BSI?
Source: International Congress 2019 – Bronchiectasis
Year: 2019
Immuno-allertypes in non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018
Non-cystic fibrosis bronchiectasis
Source: International Congress 2019 – Recent clinical advances in inhalation therapy
Year: 2019
Non-cystic fibrosis bronchiectasis
Source: Virtual Congress 2020 – Paediatric year in review
Year: 2020
Non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2017; 77: 38-57
Year: 2017
Non-cystic fibrosis bronchiectasis
Source: Eur Respir Monogr 2017; 77: 181-198
Year: 2017
Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2009; 34: 125-131
Year: 2009
Quality of life in patients with non-cystic fibrosis bronchiectasis based on radiologic findings
Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept